1 rical experience with the three-times-weekly dosage schedule.

2 th wild-type cells and treated with the same dosage schedule.

3            In our analysis, we used multiple dosage schedules and incorporated interactions among can

4 ss the relevance of key parameters including dosage, schedule, and tumor models, and describe their c

5  While future work should further refine the dosage schedule for the lightest and darkest skin types,

6                                     The oral dosage schedule of 2 g of valacyclovir TID reaches acycl

7                            PI-MED's novel UV dosage schedule produces standardized erythema responses

8  no treatment, DMSO, or NGP1-01 (dosages and dosage schedule same as above).

9 in patient sera could allow for personalized dosage schedules that lead to more successful treatments

10                                 Four vaccine dosage schedules were tested sequentially, all of which